Aggressive surgery 'treatment of choice' in childhood meningiomas 25 Nov 2011 0 comments Aggressive surgical management improves outcomes in the treatment of children with meningiomas whereas upfront radiotherapy provides no benefit.
Call for inquiry to cope with genomic breakthroughs 18 Nov 2011 0 comments Urgent changes to Australia's drug regulatory system are needed to cope with genomic discoveries that are 'fracturing' diseases.
Warning on thromboembolic risks with ADT 11 Nov 2011 0 comments Thousands of men may have been ''needlessly harmed'' as a result of a link between androgen deprivation therapy and thromboembolic events.
Pre-surgical therapy beneficial for early breast cancer 4 Nov 2011 0 comments Treating breast cancer patients pre-operatively with systemic therapies could lead to better outcomes than the usual approach of giving adjuvant therapy after surgery, experts say.
Daily aspirin reduces colorectal cancers: RCT 28 Oct 2011 0 comments Aspirin cuts the risk of colorectal cancer by 60% in Lynch syndrome patients, a landmark study shows.
Radiotherapy halves breast cancer recurrence at 10 years, reduces deaths 21 Oct 2011 0 comments Radiotherapy after breast-conserving surgery halves the rate disease recurrence at 10 years.
Gene test misses HER2 positives 14 Oct 2011 0 comments The Oncotype DX test misses 72% of HER2 positive cases and might, as a result, be less reliable than previously thought for assessing risk of recurrence.
UVA as much a ‘bad boy’ as UVB in skin cancer 7 Oct 2011 0 comments Australians should protect themselves from UVA radiation which won’t burn but can cause cancer.
Quadrivalent HPV vaccine more cost-effective: study 30 Sep 2011 0 comments The quadrivalent HPV vaccine is more cost effective than the bivalent vaccine,the most sophisticated economic model to date suggests.
‘Stop flushing cancer drugs down the toilet’: expert 23 Sep 2011 0 comments Patients are literally flushing thousands of dollars worth of oncology drugs down the toilet because of inappropriate labels, an expert argues.
